| 1 |
35128814 | Near-Infrared Fluorescent Heptamethine Cyanine Dyes for COX-2 Targeted Photodynamic Cancer Therapy. | 2022 May 4 |
1 |
| 2 |
35456720 | Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis. | 2022 Apr 18 |
1 |
| 3 |
35526488 | PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice. | 2022 Jul 12 |
1 |
| 4 |
33403674 | Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model. | 2021 Aug |
1 |
| 5 |
33593853 | Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia. | 2021 Mar 31 |
1 |
| 6 |
33793216 | From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity. | 2021 Apr 22 |
1 |
| 7 |
33837224 | Gene expression profiling of brain endothelial cells after experimental subarachnoid haemorrhage. | 2021 Apr 9 |
1 |
| 8 |
34372885 | Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice. | 2021 Aug 9 |
1 |
| 9 |
34514006 | Adipose-derived stem cells inhibit dermal fibroblast growth and induce apoptosis in keloids through the arachidonic acid-derived cyclooxygenase-2/prostaglandin E2 cascade by paracrine. | 2021 |
1 |
| 10 |
32266025 | Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model. | 2020 May |
3 |
| 11 |
32266177 | Effects of Genetic and Pharmacologic Inhibition of COX-2 on Colitis-associated Carcinogenesis in Mice. | 2020 Mar 30 |
1 |
| 12 |
32365663 | Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines. | 2020 Apr 29 |
1 |
| 13 |
32642723 | Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model. | 2020 Jan-Dec |
2 |
| 14 |
30738643 | Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly-mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair. | 2019 Feb |
1 |
| 15 |
30819896 | COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis. | 2019 Mar 19 |
1 |
| 16 |
30875493 | Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE-/- mice and lipopolysaccharide-stimulated RAW264.7 macrophages. | 2019 May |
3 |
| 17 |
31170675 | Multitarget-based cotreatment with cilostazol and celecoxib synergistically suppresses collagen-induced arthritis in mice by enhancing interleukin-10 expression. | 2019 Aug |
1 |
| 18 |
31534549 | Prostaglandin E2 induces DNA hypermethylation in gastric cancer in vitro and in vivo. | 2019 |
1 |
| 19 |
31587584 | COX-2 induces T cell accumulation and IFN-γ production during the development of chromium allergy. | 2019 Aug - Sep |
1 |
| 20 |
29132705 | IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. | 2018 Apr |
1 |
| 21 |
29371019 | Stable and sustained release liposomal formulations of celecoxib: In vitro and in vivo anti-tumor evaluation. | 2018 Apr 5 |
4 |
| 22 |
29723037 | Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. | 2018 Sep |
1 |
| 23 |
29923556 | Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis. | 2018 Jul 24 |
2 |
| 24 |
30021726 | Aspirin Suppresses PGE2 and Activates AMP Kinase to Inhibit Melanoma Cell Motility, Pigmentation, and Selective Tumor Growth In Vivo. | 2018 Oct |
1 |
| 25 |
27225385 | Enhanced Anti-Inflammatory Efficacy Through Targeting to Macrophages: Synthesis and In Vitro Evaluation of Folate-Glycine-Celecoxib. | 2017 Apr |
1 |
| 26 |
28078603 | A Comparison of the Anti-Inflammatory Effects of Cis-9, Trans-11 Conjugated Linoleic Acid to Celecoxib in the Collagen-Induced Arthritis Model. | 2017 Feb |
1 |
| 27 |
28567799 | COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels. | 2017 Aug |
1 |
| 28 |
26772819 | Anti-inflammatory therapies in TRAMP mice: delay in PCa progression. | 2016 Apr |
1 |
| 29 |
26856544 | Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension. | 2016 May |
1 |
| 30 |
27074576 | The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. | 2016 Jun 28 |
2 |
| 31 |
27159542 | Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia-like mouse model. | 2016 Mar 17 |
2 |
| 32 |
27216189 | YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis. | 2016 Jun 15 |
1 |
| 33 |
27711210 | Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice. | 2016 |
1 |
| 34 |
25503930 | Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. | 2015 Feb |
1 |
| 35 |
25909170 | HSPA12B: a novel facilitator of lung tumor growth. | 2015 Apr 30 |
1 |
| 36 |
23992553 | Development of a chitosan-derivative micellar formulation to improve celecoxib solubility and bioavailability. | 2014 Nov |
1 |
| 37 |
24486542 | Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis. | 2014 Feb 14 |
1 |
| 38 |
24900856 | Trifluoromethyl fluorocoxib a detects cyclooxygenase-2 expression in inflammatory tissues and human tumor xenografts. | 2014 Apr 10 |
1 |
| 39 |
24923427 | Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice. | 2014 Jun 12 |
2 |
| 40 |
24945311 | Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells. | 2014 Jun 18 |
1 |
| 41 |
24953691 | Effects of celecoxib on proliferation and tenocytic differentiation of tendon-derived stem cells. | 2014 Jul 18 |
1 |
| 42 |
24981602 | Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. | 2014 Sep |
2 |
| 43 |
23305077 | Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental. | 2013 Jun |
1 |
| 44 |
23657858 | Chronic elevation of IL-1β induces diuresis via a cyclooxygenase 2-mediated mechanism. | 2013 Jul 15 |
1 |
| 45 |
23770093 | The anti-inflammatory drug celecoxib inhibits T-type Ca2+ currents in spermatogenic cells yet it elicits the acrosome reaction in mature sperm. | 2013 Aug 2 |
2 |
| 46 |
23987495 | [Inhibitory effects of celecoxib combined with capecitabine on H22 hepatoma mice and its mechanism]. | 2013 Aug |
3 |
| 47 |
24349442 | A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. | 2013 |
2 |
| 48 |
22006370 | Transgenic insulin-like growth factor-1 stimulates activation of COX-2 signaling in mammary glands. | 2012 Dec |
1 |
| 49 |
22570721 | Selection of metastatic breast cancer cells based on adaptability of their metabolic state. | 2012 |
1 |
| 50 |
22641101 | Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. | 2012 Aug |
1 |